October 21, 2020

Serum Institute gets approval to resume India trial of AstraZeneca COVID vaccine: source

Serum Institute gets approval to resume India trial of AstraZeneca COVID vaccine: sourceSerum Institute of India has received Indian regulatory approval to resume local clinical trials of AstraZeneca's potential COVID-19 vaccine, a source familiar with the matter said on Wednesday. The approval came from the Drugs Controller General of India (DCGI), according to the source. AstraZeneca has resumed British clinical trials of the vaccine, one of the most advanced in development for COVID-19, after they were paused earlier this month following a serious side effect in a trial participant.


About the author  ⁄ Yahoo News - Latest News & Headlines

Comments are closed.